NUAK2 is frequently amplified in breast and liver cancers [17], where the protein activates YAP1 transcriptional activity via inhibitory phosphorylation of the Hippo pathway kinase, LATS1, which negatively regulates YAP1 [18, 19]. This evidence concerns the gene YAP1 and liver cancer.